Recce Pharmaceuticals Ltd (ASX:RCE)

Recce Pharmaceuticals Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Other Revenue	0.97	7.51	5.03	4.37	3.08	1.64
Revenue	0.97	7.51	5.03	4.37	3.08	1.64
Revenue Growth (YoY)	-89.84%	49.33%	15.19%	41.50%	88.41%	45.97%
Cost of Revenue	12.15	10.45	7.22	7.41	6.33	5.7
Gross Profit	-11.18	-2.94	-2.19	-3.05	-3.25	-4.07
Selling, General & Admin	8.81	8.36	7.09	5.75	3.54	2.29
Amortization of Goodwill & Intangibles	-	-	-	-	0.14	-
Other Operating Expenses	6.99	7.41	7.33	3.53	2.42	1.63
Operating Expenses	17.86	17.47	14.81	9.83	6.4	9.44
Operating Income	-29.04	-20.41	-17	-12.88	-9.65	-13.51
Interest Expense	-1.36	-1.21	-0.84	-0.18	-0.01	-0.01
Interest & Investment Income	0.07	0.11	0.19	0.07	0.09	0.11
Currency Exchange Gain (Loss)	0.13	0.13	-0	-	-	-
Other Non Operating Income (Expenses)	-0.05	-0.05	-0.01	-0.01	-0	-0.1
EBT Excluding Unusual Items	-30.25	-21.43	-17.66	-12.99	-9.57	-13.51
Legal Settlements	-	-	-	-0.08	-1.42	-
Pretax Income	-30.25	-21.43	-17.66	-13.08	-10.99	-13.51
Net Income	-30.25	-21.43	-17.66	-13.08	-10.99	-13.51
Net Income to Common	-30.25	-21.43	-17.66	-13.08	-10.99	-13.51
Shares Outstanding (Basic)	267	237	177	174	174	155
Shares Outstanding (Diluted)	267	237	177	174	174	155
Shares Change (YoY)	36.61%	33.81%	1.79%	-0.09%	12.05%	22.17%
EPS (Basic)	-0.11	-0.09	-0.10	-0.08	-0.06	-0.09
EPS (Diluted)	-0.11	-0.09	-0.10	-0.08	-0.06	-0.09
Free Cash Flow	-23.04	-20.47	-13.15	-12.73	-9.05	-7.93
Free Cash Flow Per Share	-0.09	-0.09	-0.07	-0.07	-0.05	-0.05
Gross Margin	-	-39.12%	-43.52%	-69.83%	-105.22%	-248.40%
Operating Margin	-2980.30%	-271.76%	-338.04%	-295.00%	-312.74%	-824.91%
Profit Margin	-3104.24%	-285.37%	-351.24%	-299.58%	-356.12%	-825.30%
Free Cash Flow Margin	-2364.45%	-272.59%	-261.53%	-291.53%	-293.38%	-484.42%
EBITDA	-28.99	-20.33	-16.93	-12.83	-9.6	-13.39
EBITDA Margin	-	-270.81%	-	-293.92%	-	-
D&A For EBITDA	0.05	0.07	0.07	0.05	0.05	0.12
EBIT	-29.04	-20.41	-17	-12.88	-9.65	-13.51
EBIT Margin	-	-271.76%	-	-295.00%	-	-
Advertising Expenses	-	1.24	1.24	1.12	0.99	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.